The first participant was dosed in a Phase 2a clinical trial testing Annexon’s investigational therapy ANX005 as a treatment for …
Diana Campelo Delgado
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.